Please assess the completion status of the following clinical trial:

Trial Title: Oral Olanzapine Versus Haloperidol or Diazepam

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Accident \& Emergency Department patients~* Requiring oral drug sedation (as determined by an emergency clinician) will be enrolled.~Exclusion Criteria:~* known hypersensitivity or contraindication to the study drugs~* reversible aetiology for agitation (e.g. hypotension, hypoxia, hypoglycaemia)~* known pregnancy~* acute alcohol withdrawal~* refusal to take oral medication~* patients from correctional facilities

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Olanzapine (Type: EXPERIMENTAL): oro-dispersible tablet (wafer)(Zyprexa), 5 mg, single dose
- Haloperidol (Type: ACTIVE_COMPARATOR): Haloperidol encapsulated tablet, 2 mg tablet, single dose
- Diazepam (Type: ACTIVE_COMPARATOR): Diazepam encapsulated tablet, 2mg tablet, single dose

Based on this trial design, predict the completion outcome and termination type (if applicable).